Navigation Links
Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
Date:6/25/2010

at reflect Soligenix, Inc.'s current expectations about its future results, performance, prospects and opportunities. Statements that are not historical facts, such as "anticipates," "believes," "intends," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. Soligenix cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including orBec®, SGX201, RiVax™, and LPM™, particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will not exceed projected levels, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development efforts, that it will be able to successfully obtain any further grants and awards, maintain its existing grants which are subject to performance, enter into any biodefense procurement contracts with the US Government or other countries, that the US Congress may not pass any legislation that would provide additional funding for the Project BioShield program, that it will be able to patent, register or protect its technology from challenge and products from competition or maintain or expand its license agreements with its current licensors, or that its business strategy will be successful. Important factors which may affect the future use of orBec® for gastrointestinal GVHD include the risks that: the FDA's requirement that Soligenix conduct additional clinical trials to demonstrate the safety and efficacy of orBe
'/>"/>
SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
2. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
3. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
4. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
5. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/d8nj6b/europe ) ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... market for Fluoroscopy is expected to grow at a ... is used to view the gastrointestinal tract, to direct ... ducts or the urinary system, to open narrowed or ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. The delivery of drugs to ... the treatment of neurological disorders. Drugs may be ... (e.g., by intravenous injection) for targeted action in ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/z9s8mp/laboratory ) has ... - Global Strategic Business Report" report to ... are provided for the period 2014 through 2020. ... these markets. Market data and analytics are derived ... primarily based on public domain information including company ...
Breaking Medicine Technology:European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2
... TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ ... ingredients (APIs), announced that its,Tainan facility has received ... The Certification confirms ScinoPharm,s,competency and proficiency in the ... applies to specific laboratories and,production areas used for ...
... , CAMBRIDGE, Mass., Nov. 19 Ligon ... to find drugs against high-value targets, today announced that ... incTANK Ventures. The company will use the capital to ... 100 high-value disease protein targets. With this investment, incTANK ...
Cached Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3
(Date:6/2/2015)... (PRWEB) June 02, 2015 The 3TVPhoenix contest, ... to watch the station’s 6:00 a.m. Good Morning Arizona program ... on the station’s Facebook page. , Lisa Allen ... participants. She plans to apply the monthly $1,000 prize ... Allen, a stay-at-home mom, expressed her surprise and gratitude at ...
(Date:6/2/2015)... India (PRWEB) June 02, 2015 Bitscape ... in the 2015 Microsoft Worldwide Small and Midsized Cloud ... field of top Microsoft partners for demonstrating excellence in ... technology. , “This comes as no surprise to ... recognized third year consecutively at worldwide level by Microsoft. ...
(Date:6/2/2015)... HERSHEY, Pa. (PRWEB) June 02, 2015 ... honored as one of the 30 members of the ... State College of Medicine. He was presented with a ... field. , “We are extremely proud of Vincent’s ... Gurt ’85. “He is a great example of how ...
(Date:6/2/2015)... RI (PRWEB) June 02, 2015 ... equipment distributor, has announced the acquisition of ... equipment distributor, effective May 29th, 2015. , With CME’s ... 2015, this latest acquisition joins three premier organizations which ... to hospitals and healthcare facilities. By combining forces, they ...
(Date:6/2/2015)... Mo. (PRWEB) June 02, 2015 With a ... Senior Living & Health Care has hired Leslie Young ... expansion of human resource initiatives to better understand and respond ... families in Tutera’s 47 communities in 13 states across the ... highest levels of personalized support to our residents, we are ...
Breaking Medicine News(10 mins):Health News:Scottsdale Resident Named $12,000 Prize Winner- Arizona Central and KTVK 3TV Phoenix Partner in Mortgage Giveaway Contest 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4
... tremor, a very common movement disorder, increases in incidence ... While voice tremors are not uncommon, the condition can ... it.// ,Previous treatments for voice tremor, such ... and are primarily recommended for treating hand tremors. Researchers ...
... recent study shows a completely artificial heart could prevent ... candidates for a heart transplant . The artificial heart ... and after transplantation. // ,The artificial heart ... transplantation in many patients who did not improve with ...
... Breast cancer may be detected earlier using a computer-assisted ... study. CAD is a computer-based analysis designed to find ... that appear only as tiny white specks on mammography ... ,Researchers reviewed the cases of 519 patients ...
... Researchers are now saying that the gene known as “mighty ... Studies on this gene arose when a German neurologist , ... well-developed muscles. Further tests revealed the child had a mutation ... producing the myostatin protein, which is known to regulate muscle ...
... found to boost the immune system and help fight off ... on children already in the hospital with severe pneumonia// and ... children with severe pneumonia recover quicker . ,The study ... About half received 20 milligrams of zinc per day while ...
... loss of liver function that can cause death within ... supportive care intended to keep patients alive long enough ... donor organ becomes available for transplantation. About 80 percent ... transplant. ,A bioartificial liver along with pig stem ...
Cached Medicine News:
... The AQT-10 is the ultimate in ... designed to detect the subtle red/green or ... disorders as retinal toxicity (that from Plaquenil, ... retinopathy, and macular degeneration. Additionally it is ...
... Amplifier (UBA-4204) from LKC Technologies, ... amplification and complete electrical isolation ... problems of DC drifting, 50/60Hz ... make the amplifier ideal for ...
... PACHETT 3 uses the exact enhanced corneal ... DGH pachymeters used exclusively by the OHTS ... into the software. The new backlit LCD ... average, standard deviation and IOP correction calculation ...
Orbital Retractor, schepens Retractors, overall length:154mm....
Medicine Products: